Non-AIDS-defining illnesses and causes of death in HIV-infected patients in St. Petersburg and Leningrad Region
https://doi.org/10.22625/2072-6732-2011-3-1-39-44
Abstract
With the aim of an evaluation of the prevalence of non-AIDS-defining illnesses and causes of death in HIVinfected patients 111 medical records of subjects admitted to the specialized hospitals in St. Petersburg in 2001–2008,were analyzed retrospectively. The most frequent non-AIDSdefining illnesses in HIV-infected patients in the era of the absence of the systematical antiretroviral therapy are gastrointestinal diseases. HIV-infected patients mostly die from generalized tuberculosis and chronic viral hepatitis at the End-Stage liver cirrhosis. To properly evaluate the preavalnce of Non-HIV-related diseases and causes of death in HIV-infected people in St. Petersburg and Leningrad region we need to conduct prospective cohort study in comparison with general population.
About the Authors
Z. M. Zagdyn
Leningrad Region AIDS Center, Saint-Petersburg
Russian Federation
Russian Federation
G. V. Volkova
City AIDS Center, Saint-Petersburg
Russian Federation
Russian Federation
A. G. Rachmanova
City AIDS Center, Saint-Petersburg
Russian Federation
Russian Federation
A. Yu. Kovelenov
Leningrad Region AIDS Center, Saint-Petersburg
Russian Federation
Russian Federation
R. Heimer
Yale university, USA
Russian Federation
Russian Federation
References
1. Lewden, С. Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS / С. Lewden [et al.] // International Journal of Epidemiology. – 2005. – № 34. – P. 121–130.
2. Palella, F.J. Mortality in the highly active antiretroviral therapy era: Changing causes of death and disease in the HIV outpatient study / F.J. Palella [et al.] // Journal of Acquired Immune Deficiency Syndromes. – September 2006. – № 43 (1). – P. 27–34.
3. Hanna, D.B. Non-HIV-related causes of death in people with AIDS in New York City, 1999–2003 / D.B. Hanna [et al.] //NYC Department of Health and Mental Hygiene. – January 27, 2005.
4. Grabar, S. Causes of the first AIDS-defining illnesses and subsequent survavial before and after the advent of combined antiretroviral therapy / S. Grabar [et al.] // HIV Med. – April 2008. – № 9 (4). – P. 246–256.
5. Ferry, T. Incidence and risk factors for the occurrence of non-AIDS-defining non-HAART-related severe linical events in HIVinfected adults in long-term follow-up, Aproco-Copilote Cohort (ANRS CO8) / T. Ferry [et al.] // 47th Interscience Conference on Antimicrobial Agents and Chemotherapy. – September 17–20, 2007. – Abstract H-1722.
6. Рахманова, А.Г. Организация лечебно-диагностических мероприятий у больных тяжелой формой ВИЧ-инфекции с сопутствующими вторичными и оппортунистическими заболеваниями / А.Г. Рахманова [и др.] // Инфекционные болезни-2007: Альманах. – СПб.: 2008. – C. 184–190.
7. Choi, A.l. The impact of HIV on chronic kidney disease outcomes / A.l. Choi [et al.] // Kidney International. – 2007. – № 72. – P. 1380–1387.
8. Inrig, Ju.K. Renal complications of HIV infection / Ju.K. Inrig [et al.] // Global HIV/AIDS Medicine. – 2007. – P. 299–307.
9. Allardice, G.M. Incidence of malignant neoplasms among HIV-infected persons in Scotland / G.M. Allardice [et al.] // British Journal of Cancer. – 2003. – № 89. – P. 505–507.
10. Bedimo, R.J. Incidence of non-AIDS-defining malignancies in HIV-infected vs. non-infected veterans in the HAART era: impact of immunosupression / R.J. Bedimo [et al.] // 47th Interscience Conference on Antimicrobial Agents and Chemotherapy. – September 17–20, 2007. – Abstract H-1721.
11. Bedimo, R.J. Trends in AIDS-defining and non-AIDSdefining malignancies among HIV-infected patients: 1989–2002 / R.J. Bedimo [et al.] // HIV/AIDS CID. – November 2004. – № 39. – P. 380–1384.
12. International Collaboration on HIV and Cancer //J. Natl. Cancer. Inst. –2000. – № 92. – P. 1823–1830.
13. Hessol, N.A. The impact of Highly Active Antiretroviral Therapy on Non-Aids defining cancers among adults with AIDS /N.A. Hessol [et al.] // American Journal of Epidemiology. – March 2007. – P. 1–11.
14. Newnham, A. The risk of cancer in HIV-infected people in southeast England: a cohort study / A. Newnham [et al.] //British Journal of Cancer. – 2005. – № 92. – P. 194–200.
15. Serlin, M.H. Gastrointestinal disorders in HIV /M.H. Serlin, D. Dieterich // Global HIV/AIDS Medicine. –2007. – P. 251–259.
16. Aberg, J.A. Cardiac disease and cancer among HIVinfected persons / J.A. Aberg // New York HIV Research Centers Consortium 2007 Scientific Conference.
17. Rickerts, V. Incidence of myocardial infarction in HIVinfected patients between 1983and 1998: The Frankfurt HIV Cohort Study / V. Rickerts [et al.] // European Journal of Med. Res. – 2000. – № 5. – P. 329–333.
18. David, M.H. Ischemic cardiovascular disease in persons with human immunodeficiency virus infection / M.H. David, R. Hornung, C.J. Fichtenbaum // Clin Infect Dis. – 2002. – № 34. – P. 98–102.
19. Hsue, P.Y. Clinical features of acute coronary syndromes in patients with human immunodeficiency virus infection /P.Y. Hsue [et al.] // Circulation. – 2004. – № 109. – P. 316– 319.
20. Boccara, F. Acute coronary syndrome in HIV-infected patients / F. Boccara // 24th Cong Eur Soc Cardiol. – 2002. –Poster 300.
21. Stein, J.H. Cardiovascular complications of HIV infection / J.H. Stein // Global HIV/AIDS Medicine. – 2007. – P. 279–286.
22. Jutte, A. Increasing morbidity from myocardial infarction during HIV protease inhibitor treatment? / A. Jutte [et al.] //AIDS. – 1999. – № 13. – P. 1796–1797.
23. Rakhlin, N. Cardiac manifestations of HIV / N. Rakhlin, P. Hsue, M.D. Cheitlin // University of California San Francisco, October 2005. – HIV InSite Knowledge Base Chapter.
24. Boccara, F. Coronary artery disease and stroke in HIVinfected patients: Prevention and pharmacological therapy /F. Boccara, C. Ariel // Adv Cardiol. – Karger, 2003. – № 40. – P. 163–184.
25. Klein, D. Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection? /D. Klein [et al.] // J. Acquir Immune Defic Syndrome. – 2002. – № 30. – P. 471–477.
26. Aoun, S. Hypertension in the HIV-infected patient /S. Aoun, E. Ramos // Curr Hypertension Rep. – 2000. –№ 2. – P. 478–481.
27. Sattler, F.R. Elevated blood pressure in subjects with lipodystrophy / F.R. Sattler [et al.] // AIDS. – 2001. – № 15. –P. 2001–2010.
28. Connor, M.D. Cerebral infarction in adult AIDS patients: Observations from the Edinburgh HIV autopsy Cohort /M.D. Connor [et al.] // Stroke. – 2000. – № 31. – P. 2117–2126.
29. Crothers, K. Increased COPD among HIV-positive compared to HIV-negative veterans / K. Crothers [et al.] //CHEST. – 2006. – № 130. – P. 1326–1333.
30. Diaz, P.T. Increased susceptibility to pulmonary emphysema among HIV-seropositive smokers / P.T. Diaz [et al.] // Annals of Internal Medicine. – March 2000. – № 132 (5). – P. 369–372.
31. O’Neil, K.M. The Changing landscape of HIV-Related Lung disease in the era of highly active antiretroviral therapy /K.M. O’Neil [et al.] // Chest. – 2002 – № 122 . – P. 768–771.
32. Weinberg, M.E. Endocrine complications of HIV infection / M.E. Weinberg [et al.] // Global HIV/AIDS Medicine. – 2007. – P. 287–298.
33. Влияние эпидемии ВИЧ-инфекции на эпидемическую ситуацию по туберкулезу в Российской Федерации. Анализ существующей информации и прогноз // Информационная бюллетень. – № 4. – Женева: ВОЗ, 2000.
34. Ермак, Т.Н. Заболеваемость и смертность от туберкулеза у взрослых больных ВИЧ-инфекцией в 15 регионах Российской Федерации в 2004–2006 гг. / Т.Н. Ермак, А.В. Кравченко, В.И. Шахгильдян // Федеральный научно-методический центр по профилактике и борьбе со СПИД Роспотребнадзора. – М., 2007.
Review
For citations:
Zagdyn Z.M., Volkova G.V., Rachmanova A.G., Kovelenov A.Yu., Heimer R. Non-AIDS-defining illnesses and causes of death in HIV-infected patients in St. Petersburg and Leningrad Region. Journal Infectology. 2011;3(1):39-44. (In Russ.) https://doi.org/10.22625/2072-6732-2011-3-1-39-44
Views:
771
.png)
.png)
Email this article 